Ross A Baker Selected Research

Aripiprazole (Abilify)

1/2019	The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies.
1/2019	Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies.
1/2018	Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study.
1/2018	The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies.
9/2017	Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study.
6/2017	Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.
1/2017	A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.
1/2017	Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY.
1/2017	Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
1/2017	Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ross A Baker Research Topics

Disease

39	Schizophrenia (Dementia Praecox) 01/2020 - 12/2007
22	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 02/2006
6	Body Weight (Weight, Body) 01/2018 - 08/2009
4	Dementia (Dementias) 12/2021 - 01/2020
4	Sleepiness 01/2020 - 07/2014
4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2010
4	Weight Gain 09/2017 - 01/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2013 - 03/2009
3	Psychomotor Agitation (Akathisia) 01/2016 - 10/2013
3	Mania (Manias) 01/2015 - 01/2011
3	Diabetes Mellitus 08/2014 - 01/2009
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2011 - 09/2010
2	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2017 - 01/2008
2	Fatigue 07/2014 - 10/2013
2	Overweight 05/2013 - 08/2009
2	Hyperprolactinemia 02/2009 - 12/2007
1	Infections 12/2021
1	Dizziness (Lightheadedness) 01/2020
1	Headache (Headaches) 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Nausea 11/2016
1	Obesity 01/2015
1	Dyslipidemias (Dyslipidemia) 08/2014
1	Psychotic Disorders (Schizoaffective Disorder) 08/2014
1	Hyperlipidemias (Hyperlipidemia) 08/2014
1	Pain (Aches) 10/2013
1	Dystonia (Limb Dystonia) 10/2013
1	Toothache (Toothaches) 10/2013
1	Tardive Dyskinesia 01/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2008
1	Gynecomastia 12/2007
1	Osteoporosis 12/2007
1	Galactorrhea 12/2007
1	Carcinogenesis 12/2007

Drug/Important Bio-Agent (IBA)

48	Aripiprazole (Abilify)FDA Link 01/2019 - 12/2008
24	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 12/2007
13	brexpiprazoleIBA 01/2021 - 01/2016
12	Antidepressive Agents (Antidepressants)IBA 01/2018 - 02/2006
6	Paliperidone Palmitate FDA Link 01/2017 - 08/2014
4	Olanzapine (Zyprexa)FDA Link 03/2009 - 12/2008
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2011
3	ProlactinIBA 09/2017 - 12/2007
3	SuspensionsIBA 03/2015 - 11/2014
3	LithiumIBA 01/2015 - 01/2011
3	Triglycerides (Triacylglycerol)IBA 08/2014 - 08/2009
3	CholesterolIBA 08/2014 - 08/2009
3	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 08/2009
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 09/2017 - 01/2017
2	TabletsIBA 01/2016 - 02/2006
2	Haloperidol (Haldol)FDA LinkGeneric 01/2015 - 01/2009
2	Hemoglobins (Hemoglobin)IBA 08/2014 - 08/2009
2	HDL CholesterolIBA 09/2010 - 08/2009
2	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2009 - 01/2009
2	LipidsIBA 12/2008 - 01/2008
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Dopamine D2 Receptor AntagonistsIBA 01/2017
1	Therapeutic UsesIBA 01/2015
1	Insulin (Novolin)FDA Link 08/2014
1	Serotonin (5 Hydroxytryptamine)IBA 07/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2014
1	Bupropion (Wellbutrin)FDA LinkGeneric 07/2014
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 07/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2013
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2013
1	Lamotrigine (Lamictal)FDA LinkGeneric 05/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2009
1	LDL CholesterolIBA 08/2009
1	Clozapine (Clozaril)FDA LinkGeneric 01/2009
1	ziprasidone (Geodon)FDA Link 01/2009
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2009
1	Blood Glucose (Blood Sugar)IBA 01/2008
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 02/2006
1	Mirtazapine (Rexer)FDA LinkGeneric 02/2006

Therapy/Procedure

13	Therapeutics 01/2019 - 08/2009
8	Injections 06/2017 - 01/2013
1	Long-Term Care 12/2021
1	Institutionalization (Institutionalized Persons) 01/2019
1	Secondary Prevention 01/2015